Gene · 5670
Papers3,544
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,544
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| mRNA vaccines in disease prevention and treatment. | Signal Transduct Target Ther | 2023 | 37726283 | PubTator, text mining | PubMed |
| Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer. | Front Pharmacol | 2023 | 37719843 | PubTator, text mining | PubMed |
| TPVB and general anesthesia affects postoperative functional recovery in elderly patients with thoracoscopic pulmonary resections based on ERAS pathway. | Transl Neurosci | 2023 | 37719744 | PubTator, text mining | PubMed |
| Identification and verification of plasma protein biomarkers that accurately identify an ectopic pregnancy. | Clin Proteomics | 2023 | 37715129 | PubTator, text mining | PubMed |
| Rosuvastatin effects on the HDL proteome in hyperlipidemic patients. | Acta Pharm | 2023 | 37708957 | PubTator, text mining | PubMed |
| A nomogram for predicting lymph node metastasis in early gastric signet ring cell carcinoma. | Sci Rep | 2023 | 37699908 | PubTator, text mining | PubMed |
| Impact of Age at Diagnosis on Clinicopathological Features, Prognosis, and Management of Gastric Cancer: A Retrospective Single-Center Experience from Spain. | Cancers (Basel) | 2023 | 37686517 | PubTator, text mining | PubMed |
| CUL4B-DDB1-COP1-mediated UTX downregulation promotes colorectal cancer progression. | Exp Hematol Oncol | 2023 | 37679762 | PubTator, text mining | PubMed |
| High expression of NOLC1 as an independent prognostic factor for survival in patients with colorectal cancer. | J Cancer Res Clin Oncol | 2023 | 37670166 | PubTator, text mining | PubMed |
| AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway. | Cell Death Dis | 2023 | 37669935 | PubTator, text mining | PubMed |
| Intratumor microbiome derived glycolysis-lactate signatures depicts immune heterogeneity in lung adenocarcinoma by integration of microbiomic, transcriptomic, proteomic and single-cell data. | Front Microbiol | 2023 | 37664112 | PubTator, text mining | PubMed |
| The Pro-Tumor Biological Function of IL-36α Plays an Important Role in the Tumor Microenvironment of HCC. | Cancer Manag Res | 2023 | 37663894 | PubTator, text mining | PubMed |
| Molecular pathology and clinical treatment of independent HPV primary serous carcinoma of the uterine cervix (USCC): A case report. | Clin Case Rep | 2023 | 37663823 | PubTator, text mining | PubMed |
| Neuroendocrine tumor of the gall bladder: A rare case report with review of literature. | Radiol Case Rep | 2023 | 37663573 | PubTator, text mining | PubMed |
| CLASRP oncogene as a novel target for colorectal cancer. | Funct Integr Genomics | 2023 | 37658940 | PubTator, text mining | PubMed |
| Serum THBS2 is a potential biomarker for the diagnosis of non-small cell lung cancer. | J Cancer Res Clin Oncol | 2023 | 37658862 | PubTator, text mining | PubMed |
| A unique case of rectal cancer with coexistence of multiple pathways of carcinogenesis. | World J Surg Oncol | 2023 | 37658412 | PubTator, text mining | PubMed |
| Genetic alterations in juvenile cervical clear cell adenocarcinoma unrelated to human papillomavirus. | Front Med (Lausanne) | 2023 | 37654657 | PubTator, text mining | PubMed |
| Four differentially expressed exosomal miRNAs as prognostic biomarkers and therapy targets in endometrial cancer: Bioinformatic analysis. | Medicine (Baltimore) | 2023 | 37653757 | PubTator, text mining | PubMed |
| Tumor-Specific Growth Factor (TSGF): A Futuristic Tumor Biomarker in Early Diagnosis of Cancer. | Adv Pharm Bull | 2023 | 37646066 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5670/papers?page=13